Naloxone hydrochloride gastro-resistant sustained release capsules as a treatment for functional constipation: a randomised, double-blind controlled trial in secondary care.

Trial Profile

Naloxone hydrochloride gastro-resistant sustained release capsules as a treatment for functional constipation: a randomised, double-blind controlled trial in secondary care.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Apr 2017

At a glance

  • Drugs Naloxone (Primary)
  • Indications Constipation
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Feb 2012 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 10 May 2011 Results presented at Digestive Disease Week 2011.
    • 05 Aug 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top